1349P Lorlatinib for advanced ROS1+ non-small cell lung cancer (NSCLC): Efficacy and safety data from IFCT-1803 LORLATU expanded access program (EAP) cohort
| Autor: | Girard, N., Girodet, S. Galland, Duruisseaux, M., Avrillon, V., Roch, B., Otto, J., Cadranel, J., Coudurier, M., Moro-Sibilot, D., Egenod, T., Lamy, R., Bennouna, J., Zalcman, G., Ricordel, C., Tillon, J., Odier, L., Besse, B., Missy, P., Westeel, V., Baldacci, S. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S865-S865 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|